ATG001
Raji CD19 Antigen Panel Cell Lines
human lymph (lymphoblast), lymphoblast
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
41106514
NACRES:
NA.41
Pricing and availability is not currently available.
Recommended Products
Product Name
Raji CD19 Antigen Panel Cell Lines,
biological source
human lymph (lymphoblast)
growth mode
suspension
morphology
lymphoblast
shipped in
dry ice
storage temp.
−196°C
General description
This product is a panel of three (3) genetically modified cell lines involving the CD19 gene. The panel consists of a CD19 knockout cell line (CD19-/-) as well as a CD19low and a CD19high expression cell line. The CD19-/- cell line was generated using CompoZr® Zinc Finger Nuclease technology, and the two CD19 expression cell lines were generated using MISSION® lentivirus. The CD19low and CD19high cell lines express CD19 at low and high levels relative to the CD19-/- cell line (CD19high > CD19low > CD19-/-) as measured via fluorescence-activated cell sorting (FACS). As a comparison, wild type Raji cells demonstrate CD19medium expression as measured via FACS.
The STR profile of these cell lines match that of its parental cell line - ECACC catalog number 85011429.
The STR profile of these cell lines match that of its parental cell line - ECACC catalog number 85011429.
Cell Line Description
Established in 1963 from Burkitt′s lymphoma in an 11 year old male. Growth is in the form of single cells without attachment and as macroscopically visible clumps containing many hundreds of cells. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. Raji is sometimes referred to as a ′non-producer′; the EBV genome carries deletions attributed to preventing the formation of virus particles. Ethnicity: Black
Features and Benefits
The Raji CD19 antigen panel cell lines feature CD19 expressed at varying levels (KO, low, and high). These cell lines enable researchers to screen and evaluate the binding and potency of CD19-targeted immunotherapies in a biologically-relevant cellular research model.
Components
ATG001A-1VL: Raji CD19 Knockout
ATG001B-1VL: Raji CD19 Low
ATG001C-1VL: Raji CD19 High
ATG001B-1VL: Raji CD19 Low
ATG001C-1VL: Raji CD19 High
Quality
Tested for Mycoplasma, bacterial and fungal content, post-freeze viability, and short terminal repeat (STR) analysis for cell line identification.
Legal Information
CompoZr is a registered trademark of Merck KGaA, Darmstadt, Germany
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class Code
10 - Combustible liquids
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
